Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Int Urol Nephrol

Retrieve available abstracts of 40 articles:
HTML format



Single Articles


    July 2022
  1. HE W, Yang J, Gao M, Liu H, et al
    Pelvic reconstruction and lateral prostate capsule sparing techniques improve early continence of robot-assisted radical cystectomy with orthotopic ileal neobladder.
    Int Urol Nephrol. 2022;54:1537-1543.
    PubMed     Abstract available


  2. BASOURAKOS SP, Al Hussein Al Awamlh B, Borregales LD, Abrahimi P, et al
    A comparative population-based analysis of peritoneal carcinomatosis in patients undergoing robotic-assisted and open radical cystectomy.
    Int Urol Nephrol. 2022;54:1513-1519.
    PubMed     Abstract available


  3. ZHU J, Lu Z, Ke M, Cai X, et al
    Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Int Urol Nephrol. 2022;54:1505-1512.
    PubMed     Abstract available


    June 2022
  4. JAFFER A, Lee M, Khalil O, Raslan M, et al
    The natural history of low-risk non-muscle-invasive bladder cancer: a collaborative multi-centre study.
    Int Urol Nephrol. 2022 Jun 27. pii: 10.1007/s11255-022-03264.
    PubMed     Abstract available


  5. TAKEN K, Aslan R, Eryilmaz R, Alp HH, et al
    Response to Letter to the Editor 'Serum irisin concentration in patients with bladder cancer'.
    Int Urol Nephrol. 2022;54:1247-1248.
    PubMed    


    May 2022
  6. ZHUANG W, Xie H, Yu S, Li Y, et al
    Effects of treatments on gender differences in patients with localized muscle-invasive bladder cancer.
    Int Urol Nephrol. 2022 May 24. pii: 10.1007/s11255-022-03200.
    PubMed     Abstract available


  7. CHIERIGO F, Borghesi M, Wurnschimmel C, Flammia RS, et al
    Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
    Int Urol Nephrol. 2022 May 4. pii: 10.1007/s11255-022-03221.
    PubMed     Abstract available


    April 2022
  8. KAWADA T
    Serum irisin concentration in patients with bladder cancer.
    Int Urol Nephrol. 2022 Apr 1. pii: 10.1007/s11255-022-03199.
    PubMed    


    March 2022
  9. ZHAO X, Wang Y, Liang C
    Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis.
    Int Urol Nephrol. 2022 Mar 25. pii: 10.1007/s11255-022-03173.
    PubMed     Abstract available


  10. YORULMAZ EM, Yilmaz Y, Kose O, Akin Y, et al
    Investigation of the causes of BCG refractory in patients treated with intracavitary BCG as secondary treatment in superficial bladder tumors with transurethral resection.
    Int Urol Nephrol. 2022;54:533-540.
    PubMed     Abstract available


    January 2022
  11. REHME C, Fritsch B, Thomas L, Istin S, et al
    Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients.
    Int Urol Nephrol. 2022;54:71-79.
    PubMed     Abstract available


    November 2021
  12. LI J, Cheng B, Xie H, Zhan C, et al
    Bladder cancer biomarker screening based on non-targeted urine metabolomics.
    Int Urol Nephrol. 2021 Nov 30. pii: 10.1007/s11255-021-03080.
    PubMed     Abstract available


  13. TAKEN K, Aslan R, Eryilmaz R, Alp HH, et al
    Serum irisin is a novel biomarker for bladder cancer detection.
    Int Urol Nephrol. 2021 Nov 22. pii: 10.1007/s11255-021-03074.
    PubMed     Abstract available


  14. PARAJULI P, Luitel BR, Pradhan MM, Chapagain S, et al
    Clinicopathological patterns of bladder carcinoma over 1 year: experience from University Hospital of Nepal.
    Int Urol Nephrol. 2021;53:2289-2294.
    PubMed     Abstract available


    September 2021
  15. GHOREIFI A, Basin MF, Ghodoussipour S, Bazargani ST, et al
    Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol.
    Int Urol Nephrol. 2021;53:1827-1833.
    PubMed     Abstract available


    July 2021
  16. SHEA C, Khawaja AR, Sofi K, Nabi G, et al
    Association of metabolic equivalent of task (MET) score in length of stay in hospital following radical cystectomy with urinary diversion: a multi-institutional study.
    Int Urol Nephrol. 2021;53:1305-1310.
    PubMed     Abstract available


    May 2021
  17. CHAN EO, Chan VW, Poon JY, Chan BH, et al
    Clear cell carcinoma of the urinary bladder: a systematic review.
    Int Urol Nephrol. 2021;53:815-824.
    PubMed     Abstract available


    April 2021
  18. SLUSARCZYK A, Garbas K, Zapala P, Zapala L, et al
    Oncological outcomes of high-grade T1 non-muscle-invasive bladder cancer treatment in octogenarians.
    Int Urol Nephrol. 2021 Apr 26. pii: 10.1007/s11255-021-02870.
    PubMed     Abstract available


    March 2021
  19. TAKAMATSU K, Matsumoto K, Kikuchi E, Ogihara K, et al
    Can random bladder biopsies be eliminated after bacillus Calmette-Guerin therapy against carcinoma in situ?
    Int Urol Nephrol. 2021;53:465-469.
    PubMed     Abstract available


    February 2021
  20. KOIE T, Hashimoto Y, Imai A, Yoneyama T, et al
    Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
    Int Urol Nephrol. 2021;53:275-280.
    PubMed     Abstract available


  21. AZEVEDO RM, de Oliveira Carneiro J, da Silva NDF, Athanazio DA, et al
    Bladder venous malformation.
    Int Urol Nephrol. 2021;53:281-282.
    PubMed    


    January 2021
  22. FARAJ KS, Navaratnam AK, Eversman S, Elias L, et al
    Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer.
    Int Urol Nephrol. 2021 Jan 3. pii: 10.1007/s11255-020-02752.
    PubMed     Abstract available


  23. YASUI M, Ohta JI, Aoki S, Tajirika H, et al
    Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa.
    Int Urol Nephrol. 2021 Jan 2. pii: 10.1007/s11255-020-02772.
    PubMed     Abstract available


    October 2020
  24. WANG Y, Shen W, Yuan X, Akezhouli S, et al
    A perioperative management to reduce rate of urinary tract infection for patient underwent radical cystectomy with ileal conduit diversion.
    Int Urol Nephrol. 2020 Oct 17. pii: 10.1007/s11255-020-02653.
    PubMed     Abstract available


    August 2020
  25. MONAGHAN TF, Flores VX, Suss NR, Robins DJ, et al
    Determinants of adequate lymph node dissection following neoadjuvant chemotherapy in patients with urothelial muscle-invasive bladder cancer: results from the National Cancer Database.
    Int Urol Nephrol. 2020 Aug 31. pii: 10.1007/s11255-020-02625.
    PubMed     Abstract available


    June 2020
  26. WU YT, Luo HL, Wang HJ, Chen YT, et al
    Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.
    Int Urol Nephrol. 2020;52:1043-1048.
    PubMed     Abstract available


    May 2020
  27. EL-HEFNAWY AS, Rizk EMAEA, Al Demerdash Khamis NM, Barakat MAA, et al
    Urinary hyaluronic acid: a versatile marker of bladder cancer.
    Int Urol Nephrol. 2020 May 1. pii: 10.1007/s11255-020-02480.
    PubMed     Abstract available


    April 2020
  28. HASSAN AA, Elbendary M, Radwan M, Abo-Farha MO, et al
    Long-term evaluation of modified orthotopic Y-shaped ileal neobladder (Tanta pouch) with left retro-colic chimney.
    Int Urol Nephrol. 2020;52:681-686.
    PubMed     Abstract available


    March 2020
  29. ANDRADE DL, Moretti TBC, Neto WA, Benedetti J, et al
    Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer.
    Int Urol Nephrol. 2020 Mar 10. pii: 10.1007/s11255-020-02438.
    PubMed     Abstract available


    February 2020
  30. MAZDAK H, Tolou Ghamari Z, Gholampour M
    Bladder cancer: total antioxidant capacity and pharmacotherapy with vitamin-E.
    Int Urol Nephrol. 2020 Feb 22. pii: 10.1007/s11255-020-02411.
    PubMed     Abstract available


  31. FENG D, Liu S, Tang Y, Yang Y, et al
    Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis.
    Int Urol Nephrol. 2020 Feb 20. pii: 10.1007/s11255-020-02406.
    PubMed     Abstract available


    January 2020
  32. ZHONG H, Shen Y, Yao Z, Chen X, et al
    Long-term outcome of spiral ileal neobladder with orthotopic ureteral reimplantation.
    Int Urol Nephrol. 2020;52:41-49.
    PubMed     Abstract available


    November 2019
  33. YAMASHITA R, Nakamura M, Notsu A, Hashizume A, et al
    The occurrence of high-grade complications after radical cystectomy worsens oncological outcomes in patients with bladder cancer.
    Int Urol Nephrol. 2019 Nov 22. pii: 10.1007/s11255-019-02341.
    PubMed     Abstract available


  34. OTTOSSON K, Pelander S, Johansson M, Huge Y, et al
    The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation.
    Int Urol Nephrol. 2019 Nov 19. pii: 10.1007/s11255-019-02338.
    PubMed     Abstract available


  35. GULLU AMURAN G, Tinay I, Filinte D, Ilgin C, et al
    Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
    Int Urol Nephrol. 2019 Nov 2. pii: 10.1007/s11255-019-02328.
    PubMed     Abstract available


  36. KHALIL MI, Alliston JT, Bauer-Erickson JJ, Davis R, et al
    Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
    Int Urol Nephrol. 2019;51:1903-1911.
    PubMed     Abstract available


    October 2019
  37. GORGEL SN, Akin Y, Koc EM, Kose O, et al
    Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre.
    Int Urol Nephrol. 2019 Oct 28. pii: 10.1007/s11255-019-02325.
    PubMed     Abstract available


  38. MCFERRIN C, Raza SJ, May A, Davaro F, et al
    Charlson comorbidity score is associated with readmission to the index operative hospital after radical cystectomy and correlates with 90-day mortality risk.
    Int Urol Nephrol. 2019;51:1755-1762.
    PubMed     Abstract available


    August 2019
  39. PARIKH N, Sharma P
    Frailty as a prognostic indicator in the radical cystectomy population: a review.
    Int Urol Nephrol. 2019;51:1281-1290.
    PubMed     Abstract available


    June 2019
  40. TSATURYAN A, Sahakyan S, Muradyan A, Fanarjyan S, et al
    A new modification of tubeless cutaneous ureterostomy following radical cystectomy.
    Int Urol Nephrol. 2019;51:959-967.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: